Natural history of initially mild chronic hepatitis C

Area of Science:

• Hepatology
• Virology
• Gastroenterology

Background:

• Hepatitis C virus (HCV) is a primary cause of chronic liver disease, cirrhosis, and hepatocellular carcinoma.
• HCV infection is heterogeneous, with many patients exhibiting mild liver disease and normal alanine aminotransferase (ALT) levels.
• Approximately 50% of HCV carriers have normal ALT, and two-thirds show mild histological liver damage.

Purpose of the Study:

• To evaluate the long-term natural history and disease progression in patients with mild chronic hepatitis C.
• To identify risk factors and predict the likelihood of severe liver fibrosis or cirrhosis development.
• To inform treatment decisions for patients with mild chronic HCV based on disease progression risk.

Main Methods:

• Analysis of population-based studies on HCV carriers with normal and elevated ALT levels.
• Review of natural history studies focusing on initially mild chronic liver disease.
• Utilizing outcome modeling projections to estimate long-term fibrosis progression risks.

Main Results:

• Short-term outcomes for mild chronic hepatitis C are generally benign.
• Long-term follow-up reveals fibrosis progression, especially with elevated/fluctuating ALT levels.
• Risk of cirrhosis is minimal (<5-10%) in 10-15 years for normal ALT carriers, but significantly higher (>30-40%) for those with elevated ALT and initial portal fibrosis (F1).

Conclusions:

• Persistently normal ALT in HCV carriers correlates with a minimal risk of severe liver disease progression.
• Elevated ALT levels, particularly with initial portal fibrosis, necessitate careful monitoring and consideration for antiviral therapy.
• Factors such as age at infection, alcohol use, coinfections, and liver steatosis accelerate disease progression in chronic hepatitis C.